Hydrogen Gas for Cancer Rehabilitation

Status Completed

Clinical Trial Summary

The aim of this study is the efficacy of hydrogen gas immunotherapy to rehabilitation and prognosis of cancer patients.

Clinical Trial Description

By enrolling patients of multiple kinds of cancer adapted to enrolled criteria, this study will document for the first time the short and long term efficacy of hydrogen gas.The evaluation indexes include peripheral blood lymphocyte immunoassay, improvement of sleep, diet and exercise, progress free survival (PFS) and overall survival (OS). ;

Study Design

Related Conditions & MeSH terms

Adult Solid Tumor

Clinical Trial Details

NCT number	NCT03818347
Study type	Interventional
Source	Fuda Cancer Hospital, Guangzhou
Contact
Status	Completed
Phase	N/A
Start date	June 2, 2018
Completion date	August 20, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06059547` - Neoadjuvant Immunotherapy in Combination With the Anti-GDF-15 Antibody Visugromab (CTL-002) for Treatment of Muscle Invasive Bladder Cancer	Phase 2
Active, not recruiting	`NCT04538625` - Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy	Phase 3
Completed	`NCT01037790` - Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer	Phase 2
Recruiting	`NCT06403436` - A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors	Phase 1
Recruiting	`NCT03061305` - Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
Active, not recruiting	`NCT02568267` - Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)	Phase 2
Terminated	`NCT05357898` - Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors	Phase 1/Phase 2
Not yet recruiting	`NCT06277804` - A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor	Phase 1
Completed	`NCT05400265` - Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor	Phase 1
Recruiting	`NCT04705818` - Combining Epigenetic And Immune Therapy to Beat Cancer.	Phase 2
Completed	`NCT01269918` - A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain	N/A
Suspended	`NCT03253575` - CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2
Completed	`NCT04084951` - Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors	Phase 1
Completed	`NCT03760952` - Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling
Active, not recruiting	`NCT03445858` - Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults	Early Phase 1
Completed	`NCT03303365` - Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence	N/A
Not yet recruiting	`NCT05666635` - Study of LTC004 in Subjects With Advanced Malignant Tumors	Phase 1
Recruiting	`NCT05752552` - Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours	Phase 1
Active, not recruiting	`NCT05147272` - Study of RP-6306 With Gemcitabine in Advanced Solid Tumors	Phase 1
Terminated	`NCT04892043` - Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors	Phase 1